Prashanth joined Brandon Capital in 2021.
Prior to this, Prashanth was Senior Commercialisation Manager at UniSA Ventures, the commercialisation and investment-management arm of the University of South Australia (UniSA). Prashanth managed a portfolio of IP commercialisation projects and conducted several complex IP transactions. Prashanth was also the Operations Manager for AbRegen, a UniSA Ventures investee company, where he provided strategic leadership to the company and helped secure funding from the EB Research Partnership to further the preclinical program.
Prashanth holds a B. Technology in Bioinformatics from Sathyabama University (India) and a PhD in Biochemistry and Molecular biology, and M. Biotech (Adv) from The University of Queensland.